Cell Reprogramming Market Size

Cell Reprogramming Market size is poised to reach USD 1 Billion by the end of 2036, growing at a CAGR of 6% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of cell reprogramming was USD 400 Million. The reason behind the growth is the rising burden of cancer across the globe. Developing nations may bear a disproportionate share of the cost of cancer incidence, morbidity, and mortality owing to rising levels of air pollution, unhealthy diets, drinking alcohol, smoking, and not moving around much. According to the World Health Organization (WHO), it is anticipated that there will be over 35 million new cases of cancer in 2050, a 77% increase over the projected 20 million cases in 2022.

The growing advancements in technology are believed to fuel market growth. For instance, researchers have reported using a cell reprogramming technique to create neural networks that mimic distinct features of human cells, which could facilitate the development of new treatments for neuropathies.